Arastoo, M.; Mazanetz, M.P.; Miller, S.; Shiells, H.; Hull, C.; Robinson, K.; Storey, J.M.D.; Harrington, C.R.; Wischik, C.M.
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants. Int. J. Mol. Sci. 2023, 24, 13747.
https://doi.org/10.3390/ijms241813747
AMA Style
Arastoo M, Mazanetz MP, Miller S, Shiells H, Hull C, Robinson K, Storey JMD, Harrington CR, Wischik CM.
Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants. International Journal of Molecular Sciences. 2023; 24(18):13747.
https://doi.org/10.3390/ijms241813747
Chicago/Turabian Style
Arastoo, Mohammad, Michael P. Mazanetz, Sonya Miller, Helen Shiells, Claire Hull, Keith Robinson, John M. D. Storey, Charles R. Harrington, and Claude M. Wischik.
2023. "Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants" International Journal of Molecular Sciences 24, no. 18: 13747.
https://doi.org/10.3390/ijms241813747
APA Style
Arastoo, M., Mazanetz, M. P., Miller, S., Shiells, H., Hull, C., Robinson, K., Storey, J. M. D., Harrington, C. R., & Wischik, C. M.
(2023). Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants. International Journal of Molecular Sciences, 24(18), 13747.
https://doi.org/10.3390/ijms241813747
